ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in ImageneBio, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- −7 vs. Q4 2024
- Shares held
- 32.7M
- +1.04M (+3.3%) vs. Q4 2024
- Total value
- $41.9M
- −$10.1M (−19.4%) vs. Q4 2024
- New holders
- 3
- 7 more added
- Sold out
- 10
- 20 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $6.42M | 1.23% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 4,091,118 | $5.24M | 1.69% | 00.0% | Unchanged |
| BVF Inc | 4,006,564 | $5.13M | 0.21% | 00.0% | Unchanged |
| BML Capital Management, LLC | 3,710,803 | $4.75M | 3.84% | +124,937+3.5% | Added |
| OrbiMed Advisors LLC | 3,539,358 | $4.53M | 0.11% | 00.0% | Unchanged |
| Deep Track Capital, LP | 2,515,513 | $3.22M | 0.10% | +2,515,513 | New |
| Omega Fund Management, LLC | 2,249,123 | $2.88M | 1.70% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,383,418 | $1.77M | 0.00% | −1,246−0.1% | Reduced |
| Gilead Sciences, Inc. | 1,159,145 | $1.48M | 0.13% | −849,193−42.3% | Reduced |
| Adage Capital Partners GP, L.L.C. | 800,000 | $1.02M | 0.00% | 00.0% | Unchanged |
| NEA Management Company, LLC | 600,063 | $768.1K | 0.06% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 382,616 | $489.7K | 0.04% | 00.0% | Unchanged |
| BlackRock, Inc. | 348,634 | $446.3K | 0.00% | −3,502−1.0% | Reduced |
| Geode Capital Management, LLC | 317,091 | $406.0K | 0.00% | −10,871−3.3% | Reduced |
| Peapod Lane Capital LLC | 296,437 | $379.4K | 0.43% | −211,431−41.6% | Reduced |
| Renaissance Technologies LLC | 294,487 | $376.9K | 0.00% | −35,713−10.8% | Reduced |
| Aldebaran Capital, LLC | 247,795 | $317.2K | 0.30% | +247,795 | New |
| Jacobs Levy Equity Management, Inc | 245,485 | $314.2K | 0.00% | −81,925−25.0% | Reduced |
| Acadian Asset Management LLC | 209,568 | $266.0K | 0.00% | −78,800−27.3% | Reduced |
| Bridgeway Capital Management, LLC | 153,300 | $196.2K | 0.00% | −500−0.3% | Reduced |
| Two Sigma Advisers, LP | 151,400 | $193.8K | 0.00% | −6,000−3.8% | Reduced |
| UBS Group AG | 100,660 | $128.8K | 0.00% | +28,804+40.1% | Added |
| State Street Corp | 92,153 | $118.0K | 0.00% | 00.0% | Unchanged |
| Deuterium Capital Management, LLC | 80,579 | $103.1K | 0.23% | 00.0% | Unchanged |
| Citadel Advisors LLC | 79,687 | $102.0K | 0.00% | −681−0.8% | Reduced |
| Two Sigma Investments, LP | 79,422 | $101.7K | 0.00% | −21,356−21.2% | Reduced |
| Squarepoint Ops LLC | 77,434 | $99.1K | 0.00% | +33,794+77.4% | Added |
| Goldman Sachs Group Inc | 76,464 | $97.9K | 0.00% | +29,369+62.4% | Added |
| BBR Partners, LLC | 70,000 | $89.6K | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 69,684 | $89.2K | 0.00% | −130,000−65.1% | Reduced |
| Barclays PLC | 66,177 | $84.7K | 0.00% | −129,134−66.1% | Reduced |
| Northern Trust Corp | 57,565 | $73.7K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 56,452 | $72.3K | 0.00% | +43,924+350.6% | Added |
| Dimensional Fund Advisors LP | 38,621 | $49.5K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 26,000 | $33.3K | 0.00% | +7,800+42.9% | Added |
| JustInvest LLC | 16,952 | $21.7K | 0.00% | +583+3.6% | Added |
| Berkshire Asset Management LLC | 20,000 | $21.6K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 12,571 | $16.1K | 0.00% | −2,832−18.4% | Reduced |
| FMR LLC | 5,063 | $6.48K | 0.00% | −5,524−52.2% | Reduced |
| JPMorgan Chase & Co | 849 | $1.09K | 0.00% | −154,892−99.5% | Reduced |
| Coldstream Capital Management Inc | 525 | $672 | 0.00% | +525 | New |
| BNP Paribas Arbitrage, SA | 315 | $403 | 0.00% | −43,725−99.3% | Reduced |
| Bank of America Corp | 221 | $283 | 0.00% | −30−12.0% | Reduced |
| Farther Finance Advisors, LLC | 108 | $135 | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 69 | $88 | 0.00% | −30−30.3% | Reduced |
| SBI Securities Co., Ltd. | 3 | $4 | 0.00% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −72,890−100.0% | Sold out |
| JBF Capital, Inc. | 0 | $0 | 0.00% | −72,647−100.0% | Sold out |
| Vazirani Asset Management LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −21,184−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −18,934−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −12,304−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,633−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,503−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −564−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −235−100.0% | Sold out |